Approval · Notice of Compliance 7621 · 2005
EMTRIVA: Notice of Compliance 7621
Issued November 21, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7621
- Date
- November 21, 2005
- Company
- Gilead Sciences, Inc.Foster City, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMTRIVA | 02272091 | Cancelled Post Market |
Medicinal ingredients
- EMTRICITABINE 200 MG per CAP